SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

02 Feb 2023 Evaluate
The revenue for the December 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Profit of the company vaulted to 2636.36% to Rs. 3.01  millions from Rs. 0.11 millions in the previous quarter.The company reported a good operating profit of 3.01 millions compared to 0.11 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 -15.37 24.75 -162.10 21.62 0.15 14313.33
Other Income 3.25 0.29 1020.69 23.75 -1.35 -1859.26 0.07 0.00 0.00
PBIDT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 -42.42 9.01 -570.81 -0.37 -10686.67 -100.00

Biogen Pharmachem Share Price

0.47 0.01 (2.17%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 223.40
Adani Enterprises 2539.40
Amrapali Industries 18.69
Rashi Peripheral 500.90
PDS 288.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×